lock Open Access lock Peer-Reviewed




Risk Factors for Mortality in Children with Congenital Heart Disease Delivered at a Brazilian Tertiary Center

Luciane Alves RochaI; Sthefane Catib FroioI; Célia Camelo SilvaII; Simone de Araujo Negreiros FigueiraIII; José Cícero Stocco GuilhenIV; Ruth GuinsburgIII; Edward AraujoI

DOI: 10.21470/1678-9741-2018-0174


Objective: This study aims to investigate the incidence of postnatal diagnosis of congenital heart disease (CHD) and the predictive factors for hospital mortality.
Methods: This retrospective cohort study was conducted at a Brazilian tertiary center, and data were collected from medical records with inclusion criteria defined as any newborn with CHD diagnosed in the postnatal period delivered between 2015 and 2017. Univariate and multivariate analyses were performed to determine the potential risk factors for mortality.
Results: During the 3-year period, 119 (5.3%) children of the 2215 children delivered at our institution were diagnosed with CHD. We considered birth weight (P=0.005), 1st min Apgar score (P=0.001), and CHD complexity (P=0.013) as independent risk factors for in-hospital mortality. The most common CHD was ventricular septal defect. Indeed, 60.5% cases were considered as "complex" or "significant" CHDs. Heart surgeries were performed on 38.9% children, 15 of whom had "complex" or "significant" CHD. A mortality rate of 42% was observed in this cohort, with 28% occurring within the initial 24 h after delivery and 38% occurring in patients admitted for heart surgery.
Conclusion: The postnatal incidence of CHD at our service was 5.3%. Low 1st min Apgar score, low birth weight, and CHD complexity were the independent factors that affected the hospital outcome.


CHD = Congenital heart disease

ECMO = Extracorporeal membrane oxygenation

EPM-UNIFESP = Paulista School of Medicine, Federal University of São Paulo

RACHS = Risk adjustment for congenital heart surgery


Congenital heart diseases (CHDs), the leading abnormalities in fetuses, are six times more common than chromosomal abnormalities and four times more common than neural tube defects[1]. The incidence of CHD with intrauterine diagnosis ranges from 2.4% to 54%[2-7]. However, some countries witness high incidence of CHD possibly due to the implementation of an organized policy to perform ultrasound heart screening[8-10]. In Brazil, CHDs are the main cause of death among infants with congenital abnormality, and the implementation of health public policies targeting such population may decrease infant mortality, as occurred in developed countries[11].

A comprehensive assessment of the fetal heart optimizes the diagnosis of CHD, offering appropriate prenatal and postnatal planning and facilitating an improvement in neonatal morbidity and surgical outcome[10,12-17]. Newborns with postnatal diagnosis could have unfavorable outcomes because symptoms and cardiovascular impairment may develop at home or in a community hospital, further increasing the morbidity and mortality rates.

Previously, a few studies focused on surgical and hospital outcomes[9], encouraging us to document our experience with newborns with CHD at our service. Thus, the aim of our study was to define the current postnatal incidence of CHD at one Brazilian referral center and to determine the risk factors that may affect the hospital outcome.


This historical cohort study was conducted at one referral center [São Paulo Hospital at Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP, São Paulo, Brazil)] having expertise in fetal and pediatric echocardiography and critical care for complex CHDs in Southeast Brazil, however, without extracorporeal membrane oxygenation (ECMO).

Data were collected from the medical records of pregnant women and their newborns diagnosed with CHD. The study protocol was approved by the Ethics Committee of UNIFESP.

In this study, the inclusion criteria were newborns with postnatal diagnosis of CHD delivered at our service between January 2015 and December 2017, regardless of the center where the prenatal follow-up was conducted. Patients with inadequate echocardiographic data were excluded from the final analysis. We used the classification system of fetal heart diseases based on the complexity of anatomical heart abnormalities[18,19]. "Complex CHDs" included heterotaxy or atrial isomerism, atresia or severe hypoplasia of a valve or chamber (hypoplastic left heart syndrome, pulmonary atresia, tricuspid atresia, aortic atresia, mitral atresia, and Ebstein's anomaly), and abnormalities of the valve inlet or outlet (complete atrioventricular septal defect, truncus arteriosus, double inlet left or right ventricle, and double outlet left or right ventricle congenitally corrected transposition of the great arteries). "Significant CHDs" included transposition of the great vessels, tetralogy of Fallot, large ventricular septal defect, coarctation of the aorta, aortopulmonary window, critical aortic or pulmonary stenosis, partial atrioventricular septal defect, total anomalous pulmonary venous connection, and tricuspid valve dysplasia (no Ebstein's anomaly). "Minor CHDs" included small ventricular septal defect and less severe aortic or pulmonary stenosis, whereas dysrhythmias, cardiomyopathies, secondary dextrocardia/levocardia, pulmonary sequestration, and patent ductus arteriosus were classified as "other CHDs"[18,19].

Furthermore, newborns were categorized undergoing surgery depending on the study of risk adjustment for in-hospital mortality of children undergoing congenital heart surgery (designated as RACHS - Risk adjustment for congenital heart surgery)[20]. RACHS can be used in the comparative assessment of outcomes among institutions to guide quality improvement efforts. In this study, independent variables included gestational age at delivery (weeks), birth weight (g), prematurity, 1st and 5th min Apgar score, karyotype analysis, presence of extracardiac malformations, type of delivery, type of CHD, clinical and surgical treatments for CHD, need for mechanical ventilation, antibiotics, and vasoactive drugs, and the dependent variable was hospital mortality.

Means and standard deviations were calculated for quantitative variables, and percentage and absolute values were described for qualitative variables. Subsequently, an inferential analysis of the study variables was conducted. The unpaired Student's t-test was used for quantitative variables and chi-square or Fisher's exact test for qualitative variables. For all analyses, P-values of <0.05 was considered statistically significant. All baseline variables with univariate analysis exhibiting P<0.10 were selected for logistic regression analysis.

The analyses were performed using the program STATA/IC 12.1 (College Station, TX, USA) for MacBook (Apple Inc., Cupertino, CA, USA).


During the 3-year study period, 2215 children were born at our institution, of whom 119 (5.3%) were diagnosed with CHD, and no child was excluded in this study. Table 1 summarizes the study population, stating that the prenatal diagnosis of CHD was 84.8%.

Table 1 - Baseline characteristics of patients (n=119).
Maternal age in years, mean ± SD 30±7.9
Maternal age ≥35 years, n (%) 36 (31.5)
Prenatal diagnosis of CHD, n (%) 101 (84.8)
Gestational age at delivery in weeks, mean ± SD 36.8±2.7
Prematurity, n (%) 38 (31.9)
Cesarean, n (%) 83 (69.7)
Birth weight in gram, mean ± SD 2512±789
Birth weight ≤ 2500 g, n (%) 56 (47)
1st min Apgar score, mean ± SD 6.4±2
5th min Apgar score, mean ± SD 7.8±2
Multiple fetal malformations, n (%) 65 (54)
Neurological system 26
Facial 17
Respiratory system 3
Gastrointestinal tract 9
Genital 3
Abdominal 7
Urinary tract 9
Arms and limbs 24
Chromosomal abnormalities, n (%) 32 (26.8)
Trisomy 21 12
Trisomy 18 11
Trisomy 13 7
Others 2

CHD=congenital heart disease; SD=standard deviation

Table 1 - Baseline characteristics of patients (n=119).

The mean maternal age was 30±7.9 years, and 31.5% were aged ≥ 35 years. The mean gestational age at delivery was 36±5 (range, 34-39) weeks. Approximately 31% children were prematurely born, and 47% had low birth weight. In addition, neurological disorders (48.8%) were found to be the most common malformations associated with CHD, and trisomy 21 (37.5%) and trisomy 18 (34.3%) were the leading chromosomal abnormalities.

We considered 72 (60.5%) cases as "complex" and "significant" according to the classification system of CHDs based on the complexity of anatomical heart abnormalities. Our study reported ventricular septal defect to be the most common CHD (Table 2). In the delivery room, resuscitation was conducted in 36.1% of the children; of these, 14.3% required intubation. Most children needed mechanical ventilation and vasoactive drugs during hospitalization (59.7% and 50.3%, respectively). Furthermore, heart surgery was performed in 38.9% of the children (Table 3).

Table 2 - Congenital heart disease by the classification system according to the complexity of anatomical heart abnormalities (n=119).
Congenital heart disease Frequency
Complex 51
Heterotaxy or atrial isomerism 2
Hypoplastic left heart syndrome 11
Pulmonary atresia 8
Tricuspid atresia 2
Ebstein’s anomaly 2
Truncus arteriosus 2
Complete atrioventricular septal defect 17
Double outlet of right ventricle 6
Ectopia cordis 1
Significant 21
Tetralogy of Fallot 6
Transposition of the great vessels 2
Critical pulmonary stenosis 1
Coarctation of the aorta 11
Total anomalous pulmonary venous connection 1
Minor 40
Small ventricular septal defect 28
Atrial septal defect 11
Less severe pulmonary stenosis 1
Others 7
Cardiomyopathies 1
Secondary dextrocardia/levocardia 3
Persistent ductus arteriosus 3
Table 2 - Congenital heart disease by the classification system according to the complexity of anatomical heart abnormalities (n=119).
Table 3 - Interventions performed in the study population (n=119).
Variables N(%)
Resuscitation in the delivery room, n (%) 43 (36.1)
Positive pressure ventilation, n (%) 42 (35.3)
Intubation in the delivery room, n (%) 17 (14.3)
Mechanical ventilation, n (%) 71 (59.7)
Parenteral nutrition, n (%) 56 (47)
Cardiac surgery, n (%) 46 (38.9)
Antibiotics, n (%) 27 (23)
Vasoactive drug, n (%) 59 (50.3)
Table 3 - Interventions performed in the study population (n=119).

Figure 1 shows the frequency of surgical cases based on the study of risk adjustment for in-hospital mortality of children after undergoing surgery for CHD (designated RACHS). In addition, mortality can be observed for each risk category. The highest mortality rate was observed in category 6 (66.7%). Among the patients admitted for surgery but who died, a tendency of correlation with the complexity of the disease was noted (P=0.08).

Fig. 1 - The frequency of surgical cases and mortality based on the study RACHS (n=46).

Mortality was observed in 42% cases (n=50), of which 14 (28%) occurred within the initial 24 hours after delivery, and the average time of death was 19 days. In addition, 18 (38%) cases of death were recorded among patients admitted for heart surgery, 15 of whom had a "complex" or "significant" CHD. Because variables such as weight, prenatal diagnosis, 1st min Apgar score, chromosomal abnormalities, and CHD complexity correlate with mortality (P<0.10) in the univariate analysis, they were selected for logistic regression. Finally, we considered low birth weight (P=0.005), low 1st min Apgar score (P=0.001), and CHD complexity (P=0.013) as independent risk factors for hospital mortality (Table 4).

Table 4 - Mortality rates in the study population and associated factors (n=50).
Variables Death P
Maternal age in years, mean ± SD 30.6 ± 7.1 0.49(1)
Gestational age at delivery in weeks, mean ± SD 36.4 ± 3.3 0.22(1)
Prematurity, n (%) 16 (32) 0.98(2)
Birth weight in gram, mean ± SD 2228.5±863        0.0007(1)/(*)
Prenatal diagnosis, n (%) 47 (94)    0.02(2)/(*)
Cesarean, n (%) 37 (74) 0.39(2)
1st min Apgar score, mean ± SD 6.4±2 <0.0001(1)/(*)
Multiple fetal malformations, n (%) 29 (58) 0.34(2)
Chromosomal abnormalities, n (%) 18 (36)     0.08(2)/(*)
Complexity of the CHD, n (%)        0.08(3)/(*)
 Complex 28 (56)  
 Significant 7 (14)  
 Minor 12 (24)  
 Others 3 (6)  

(1) Student’s t-test.

(2) Chi-square test.

(3) Fisher’s exact test.

* Variables selected for logistic regression test.

CHD=congenital heart disease; SD=standard deviation

Table 4 - Mortality rates in the study population and associated factors (n=50).


This study demonstrated that the current frequency of postnatal detection of CHD at our service is 5.3%. The variables low 1st min Apgar score, low birth weight, and CHD complexity were independent factors that affected hospital mortality.

Similar to previous studies, we established that the postnatal incidence of CHD is high at our center[21,22] possibly due to the absence of laws that facilitate the interruption of gestation in Brazilian patients with CHD[9,15,17]. Moreover, patients are referred to a tertiary center after prenatal diagnosis, thereby increasing the incidence of CHD at our institute. Additionally, in the univariate analysis, the prenatal diagnosis was associated with death probably due to the same fact that our institution is tertiary. A study comparing the surgical results of between children with intrauterine diagnosis and postnatal diagnosis may clarify such finding.

The higher prevalence of "complex" and "significant" CHD can also be attributed to the fact that our hospital is a reference center for CHD. Besides, the routine use of Doppler echocardiography has increased the diagnosis of "minor" defects (i.e., small ventricular septal defect, milder forms of pulmonary stenosis, and atrial septal defect) in asymptomatic children. In fact, some studies have reported a high frequency of ventricular septal defect[22], as established in our study.

Reportedly, low birth weight is associated with increased mortality rate in patients admitted for heart surgery[23,24]. Remarkably, we determined that low birth weight was an independent risk factor for hospital mortality regardless of patients being admitted for surgery or not. In addition, other studies have established a correlation between prematurity and increased mortality rate, rather than low birth weight; however, such association was not determined in our analysis[25,26]. Low birth weight is also often associated with other major congenital anomalies, which might affect morbidity and mortality. Consequently, such cases are the most complicated and severe ones in the delivery room, presenting an increased risk of having a lower 1st min Apgar score (other independent risk factors for mortality that were found).

Previous studies have reported early mortality rates ranging from 10% to 42%[22,27]; however, studies that reported the lowest mortality rate included no patients with functionally univentricular physiology and all their patients could undergo surgery at a single stage[27]. The mortality rate of our patients admitted for heart surgery was 38%, which could be attributed to the high complexity of heart diseases at our service (85% of cases operated) with the majority of patients with functionally univentricular physiology. The mortality rate was slightly higher (66.7%) in our study than the expected mortality rate (47.7%) for RACHS risk 6[20]. Probably, multifactorial causes justify our suboptimal results. The absence of ECMO in our institution[28], as well as not measured aspects related to hospital infra-structure, human resources or children nutritional state may be associated. Despite of this, such results showed us that we need to improve the quality of the data collection in order to identify flaws during the preoperative, intraoperative and/or postoperative course.

However, our study had several drawbacks, many of which are attributed to the retrospective study design. Moreover, we did not collect the prenatal echocardiographic data and used the hospital mortality as an outcome. The lack of representative ambulatory data precluded comprehensive analysis of the prognosis. Furthermore, the absence of intraoperative and postoperative data as well as specific causes of the mortality prevented us from differentiating the primary cause of mortality.


In conclusion, this study reports that the postnatal incidence of CHD at our service was 5.3% and that low 1st min Apgar score, low birth weight, and CHD complexity are independent factors, affecting hospital outcome. The results of this study could contribute to the development of policies that improve mortality rates.


1. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, ThilaganathanB. Improving the effectiveness of routine prenatal screening for majorcongenital heart defects. Heart. 2002;88(4):387-91.

2. Yu Z, Xi Y, Ding W, Han S, Cao L, Zhu C, et al. Congenital heartdisease in a Chinese hospital: pre- and postnatal detection, incidence, clinicalcharacteristics and outcomes. Pediatr Int. 2011;53(6):1059-65.

3. Ozbarlas N, Erdem S, Küçükosmanoglu O, Seydaoglu G, Demir C, EvrükeC, et al. Prevalence and distribution of structural heart diseases in high andlow risk pregnancies. Anadolu Kardiyol Derg. 2011;11(2):125-30.

4. Lee JE, Jung KL, Kim SE, Nam SH, Choi SJ, Oh SY, et at. Prenataldiagnosis of congenital heart disease: trends in pregnancy termination rate, andperinatal and 1-year infant mortalities in Korea between 1994 and 2005. J ObstetGynaecol Res. 2010;36(3):474-8.

5. Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J,Sorenson B, et al. Prenatal detection of congenital heart disease. J Pediatr.2009;155(1):26-31.

6. Clur SA, Van Brussel PM, Mathijssen IB, Pajkrt E, Ottenkamp J,Bilardo CM. Audit of 10 years of referrals for fetal echocardiography. PrenatDiagn. 2011;31(12):1134-40.

7. Galindo A, Herraiz I, Escribano D, Lora D, Melchor JC, Cruz J.Prenatal detection of congenital heart defects: a survey on clinical practice inSpain. Fetal Diagn Ther. 2011;29(4):287-95.

8. Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J,Sorenson B, et al. Prenatal detection of congenital heart disease. J Pediatr.2009;155(1):26-31.

9. Garne E, Stoll C, Clementi M; Euroscan Group. Evaluation of prenataldiagnosis of congenital heart diseases by ultrasound: experience from 20European registries. Ultrasound Obstet Gynecol.2001;17(5):386-91.

10. Dolk H, Loane M, Garne E; European Surveillance of CongenitalAnomalies (EUROCAT) Working Group. Congenital heart defects in Europe:prevalence and perinatal mortality, 2000 to 2005. Circulation.2011;123(8):841-9.

11. Caneo LF, Jatene MB, Yatsuda N, Gomes WJ. A reflection on theperformance of pediatric cardiac surgery in the State of São Paulo. Rev Bras CirCardiovasc. 2012;27(3):457-62.

12. Araujo Júnior E, Rolo LC, Nardozza LM, Moron AF. Fetal cardiacevaluation by 3D/4D ultrasonography (STIC): what is its real applicability inthe diagnosis of congenital heart disease? Rev Bras Cir Cardiovasc.2013;28(1):III-V.

13. Allan L. Prenatal diagnosis of structural cardiac defects. Am J MedGenet C Semin Med Genet. 2007;145C(1):73-6.

14. Bull C. Current and potential impact of fetal diagnosis onprevalence and spectrum of serious congenital heart disease at term in the UK.British Paediatric Cardiac Association. Lancet.1999;354(9186):1242-7.

15. Hoffman JI. Incidence of congenital heart disease: II. Prenatalincidence. Pediatr Cardiol. 1995;16(4):155-65.

16. Souza AH, Fonseca L, Franchi SM, Lianza AC, Baumgratz JF, Silva JP.The hypoplastic left heart syndrome is not a risk factor for Fontan operation.Rev Bras Cir Cardiovasc. 2010;25(4):506-9.

17. Rocha LA, Araujo Júnior E, Rolo LC, Barros FS, Silva KP, Leslie AT,et al. Prenatal detection of congenital heart diseases: one-year surveyperforming a screening protocol in a single reference center in Brazil. CardiolRes Pract. 2014;2014:175635.

18. Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis ofcongenital heart disease in the northern region of England: benefits of atraining programme for obstetric ultrasonographers. Heart.2000;84(3):294-8.

19. Wren C, Richmond S, Donaldson L. Temporal variability in birthprevalence of cardiovascular malformations. Heart.2000;83(4):414-9.

20. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, IezzoniLI. Consensus-based method for risk adjustment for surgery for congenital heartdisease. J Thorac Cardiovasc Surg. 2002;123(1):110-8.

21. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A.Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. JPediatr. 2008;153(6):807-13.

22. Holland BJ, Myers JA, Woods CR Jr. Prenatal diagnosis of criticalcongenital heart disease reduces risk of death from cardiovascular compromiseprior to planned neonatal cardiac surgery: a meta-analysis. Ultrasound ObstetGynecol. 2015;45(6):631-8.

23. Curzon CL, Milford-Beland S, Li JS, O'Brien SM, Jacobs JP, JacobsML, et al. Cardiac surgery in infants with low birth weight is associated withincreased mortality: analysis of the Society of Thoracic Surgeons CongenitalHeart Database. J Thorac Cardiovasc Surg. 2008;135(3):546-51.

24. Kalfa D, Krishnamurthy G, Duchon J, Najjar M, Levasseur S, Chai P,et al. Outcomes of cardiac surgery in patients weighing &lt;2.5 kg: affectof patient-dependent and -independent variables. J Thorac Cardiovasc Surg.2014;148(6):2499-506.

25. Costello JM, Polito A, Brown DW, McElrath TF, Graham DA, ThiagarajanRR, et al. Birth before 39 weeks' gestation is associated with worse outcomes inneonates with heart disease. Pediatrics. 2010;126(2):277-84.

26. Costello JM, Pasquali SK, Jacobs JP, He X, Hill KD, Cooper DS, etal. Gestational age at birth and outcomes after neonatal cardiac surgery: ananalysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.Circulation. 2014;129(24):2511-7.

27. Ades AM, Dominguez TE, Nicolson SC, Gaynor JW, Spray TL, WernovskyG, et al. Morbidity and mortality after surgery for congenital cardiac diseasein the infant born with low weight. Cardiol Young.2010;20(1):8-17. [MedLine]

28. Conrad SJ, Bridges BC, Kalra Y, Pietsch JB, Smith AH. Extracorporealcardiopulmonary resuscitation among patients with structurally normal hearts.ASAIO J. 2017;63(6):781-6. [MedLine]

No financial support
No conflict of interest

Authors' roles & responsibilities

LAR Writing and statistical analysis; final approval of the version to be published

SCF Collect data; final approval of the version to be published

CCS Collect data; final approval of the version to be published

SANF Critical review; final approval of the version to be published

JCSG Critical review; final approval of the version to be published

RG Supervision; final approval of the version to be published

EAJ Supervision; final approval of the version to be published

Article receive on Tuesday, April 24, 2018

CCBY All scientific articles published at are licensed under a Creative Commons license


All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY